Brevan Howard Capital Management »

Theravance Biopharma shares owned by Brevan Howard Capital Management

Quarter-by-quarter ownership of Theravance Biopharma (TBPH) shares owned by Brevan Howard Capital Management from 13F filings

Historical chart of Brevan Howard Capital Management investment in Theravance Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Theravance Biopharma held by Brevan Howard Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Theravance Biopharma by Brevan Howard Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $89k 11k 8.06
2024-06-30 $252k 30k 8.48
2024-03-31 $221k 25k 8.97
2023-12-31 $284k 25k 11.24

More positions owned by Brevan Howard Capital Management

Ishares Msci Emerging Mkt In Msci Emg Mkt Etf (EEM)
Financial Select Sector Spdr Financial Call Option (XLF)
Ishares Ftse/xinhua China 25 China Lg-cap Etf Call Option (FXI)
Invesco QQQ Trust Series 1 Nasdaq100 BB:QQQ Unit Ser 1 (QQQ)
Ishares Iboxx H/y Corp Bond Iboxx Hi Yd Etf Call Option (HYG)
Industrial Select Sect Spdr Indl Call Option (XLI)
Consumer Staples Spdr Sbi Cons Stpls Call Option (XLP)
Health Care Select Secto Sbi Heathcare Call Option (XLV)
Ishares Russell 2000 Etf Russell 2000 Etf (IWM)
Spdr S&p Biotech Etf S&p Biotech (XBI)
KraneShares CSI China Internet ETF Csi Chi Internet Call Option (KWEB)
Energy Select Sector Spdr Energy Call Option (XLE)
Alibaba Group Holding Sponsored Ads (BABA)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)

View all positions for Brevan Howard Capital Management

Top funds holding Theravance Biopharma

Weiss Asset Management LP[1
Newtyn Management
BlackRock
BlackRock
Irenic Capital Management
Vanguard Group
Park West Asset Management
State Street Corporation
Geode Capital Management
D. E. Shaw & Co
Pictet Asset Management Holding SA
Jacobs Levy Equity Management
Bank of America Corporation
Morgan Stanley
Dimensional Fund Advisors

View all funds holding Theravance Biopharma